ActiTrexx
ActiTrexx GmbH prevent the development of GvHD at an early stage with the cellular therapy ATreg and thus to provide a curative therapy
ActiTrexx has raised €3.5M across 1 funding round from 1 investor, most recently a round in Mar 2021. Based in Mainz, Germany; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.5M
€3,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-03
latest 2021-03
Funding by year
EUR raised per yearActiTrexx — funding by year — interactive chart.
Data table
| ActiTrexx — funding by year | |
|---|---|
| 2021 | €3.5M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-03-02 | Other | €3.5M | LBBW Venture Capital GmbH | View deal → |
Investors
1Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData